Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2029

Conditions

Anaemia in Ovarian Carcinoma

Interventions

DRUG

IV iron

Intravenous Iron supplement

Trial Locations (2)

Allan Blair Cancer Centre, Regina

Saskatoon Cancer Centre, Saskatoon

All Listed Sponsors

lead

University of Saskatchewan

OTHER

NCT06248749 - Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer | Biotech Hunter | Biotech Hunter